Aspichueta Lab (Lipids & Liver)

@aspichuetaLab

Studying metabolic pathways involved in Liver diseases. Department Physiology, UPV/EHU, Biobizkaia

País Vasco, España ehu.eus/es/web/lipidsl… Joined October 2018

713 Following 786 Followers 724 Posts

Latest posts 5

Aspichueta Lab (Lipids & Liver) @aspichuetaLab Jun 6

📣📣E2F2 transcripción factor plays and important role in liver diseases.
It modulates miR34a controlling bile acid metabolism in MASH.
@MApodakaBiguri @RuiCastroHD

SEBBM @SEBBM_es Jun 5

💡 #ArticuloMesJunio por el grupo @aspichuetaLab

E2F2 transcription factor promotes a cholestatic MASH phenotype by regulating hepatobiliary metabolism through miR-34a-5p

👉f.mtr.cool/akyesrogzj

View quoted post on X

Aspichueta Lab (Lipids & Liver) @aspichuetaLab Jun 1

Congrats @MApodakaBiguri ! more than deserved!!! And Thank you to #EASL2026

Maider @MApodakaBiguri May 31

Wrapping up a productive week at #EASL2026 in Barcelona. It was a great opportunity to learn, share our work, and connect with colleagues.

Honored to receive a Best Poster Presentation award and grateful for this recognition.

View quoted post on X

Aspichueta Lab (Lipids & Liver) @aspichuetaLab Feb 11

En Día Internacional de la Mujer y la Niña en la Ciencia 🧫🧪 apostamos por las científicas, presentes y futuras 💜🔬

On the Interntional Day of Women and Girls in Science 🧫🧪 we bet on women scientists, present and future💜🔬

#11F #Lipids&Liver

Aspichueta Lab (Lipids & Liver) @aspichuetaLab Oct 30, 2025

Congrats Maider!!

Patricia Aspichueta @PAspichueta Oct 30, 2025

📣Congrats to Maider Apodaka-Biguri for her PhD defense!!! A beautiful day surrounded by a wonderful PhD Committee and all lab members and family and not to forget the interesting discussion! ⁦@BGosan⁩ #patrickrensen ⁦@CUBEROlab⁩

View quoted post on X

Aspichueta Lab (Lipids & Liver) @aspichuetaLab Sep 6, 2025

Felicidades Maider, muy merecido por tu esfuerzo y dedicación @aspichuetaLab 👏🏻👏🏻👏🏻

SEBBM @SEBBM_es Sep 5, 2025

Grupo: Regulación Metabólica y Nutrición. Felicidades, Maider Apodaka Biguri (UPV/EHU, Bilbao). Eje E2F2–PCSK9 en MASLD: dislipidemia y hepatocarcinogénesis. Con el apoyo de @FundacionBBVA. @MApodakaBiguri @upvehu

View quoted post on X